Yes, Biodesix, Inc. is a publicly traded corporation whose shares of common stock are listed on the Nasdaq Global Market under the official ticker symbol BDSX. Trading as a public entity provides the organization with access to institutional capital markets to fund its ongoing diagnostic research, clinical validation studies, and commercial expansion efforts, while allowing public investors to buy and sell equity ownership through standard brokerage accounts.